Magnetoencephalography Devices Market

Global Magnetoencephalography Devices Market Summary:

According to Transpire Insights, a detailed research report on the market reflects that the clinical neurology and epilepsy diagnosis application segment dominates the global Global Magnetoencephalography Devices Market, accounting for approximately 64% of the total share worldwide. MEGIN Oy leads the market with approximately (around USD 121 million) in annual revenue and an estimated 48–52% global market share, making it the leading contributor to global market development, innovation, advanced magnetoencephalography device technologies, expanding functional brain mapping and neurodiagnostic capabilities, and growth dynamics.

Market Snapshot

• Market Value (2025): USD 348.6 Million.
• Expected Market Value (2026): USD 374.8 Million.
• Estimated Market Value (2033): USD 622.7 Million.
• Forecast CAGR (2026–2033): 7.52%.
• Leading Region in 2025: North America
• Second-largest Region: Europe
• Fastest Growing Region: Asia-Pacific

Introduction

The global magnetoencephalography (MEG) devices market is expected to rise steadily over the next several years because to the rising prevalence of neurological illnesses, increased demand for non-invasive brain imaging, and ongoing advancements in cryogen-free and portable MEG technologies. The market includes sensitive neuroimaging devices, data analysis software, and related services used by hospitals, diagnostic centers, and research institutes. Magnetoencephalography (MEG) detects extremely weak magnetic fields caused by neural activity. MEG may be used to map the brain in real time, with high temporal and spatial precision. Increased application in epilepsy diagnosis, pre-surgical planning, neuroscience research, cognitive studies, and functional brain mapping, as well as improved diagnostic accuracy and advancements in neurological healthcare worldwide, are also driving market growth.

 For instance:- North American Market Leader:- North America has the largest MEG market because to its advanced healthcare infrastructure, increased detection of neurological illnesses, and growing acceptance of MEG equipment for epilepsy evaluation and surgery planning.

Investment and Technological Development:- Novel OPM-MEG technologies are increasingly being developed, allowing for tiny, flexible, and wearable brain imaging solutions while overcoming the constraints of standard cryogenic MEG systems.

 Key Market Highlights: -

1. North America is expected to grow at a rapid CAGR in the Global Magnetoencephalography Devices Market by holding around40% of the share during the forecast period. 
2. Europe is anticipated to hold roughly31% share of the Global Magnetoencephalography Devices Market over the predicted timeframe. 
3. Asia Pacific is anticipated to hold nearly 23% share of the Global Magnetoencephalography Devices Market over the predicted timeframe. 
4. By Product Type, the Whole-head MEG Systems dominated the market and holds nearly 60% share in 2025 and is projected to grow at a substantial CAGR during the forecast period. 
5. By Application, Neurology dominated the market and holds close to 43% share in 2025 and is projected to grow at a substantial CAGR during the forecast period. 
6. By End User, the Hospitals segment dominated the market and holds about 65% share in 2025 and is projected to grow at a substantial CAGR during the forecast period. 
7. Government initiatives, healthcare research funding, and defense programs that promote advanced neuroimaging research, quantum-based brain scanning technologies, and the creation of innovative medical imaging solutions around the world all help to drive the MEG market forward.

How is Technology Driving Growth in the Global Magnetoencephalography Devices Market?

The technological advancements in the system portability, accuracy and accessibility are driving the growth of the MEG devices market. Innovations in optically pumped magnetometers (OPMs) are creating opportunities for helium-free, wearable, and low-cost solutions to brain imaging. AI and machine learning integration improves automated detection and analysis of data for neurological disorders. Moreover, the integration of multimodal imaging with MRI and PET, and the advent of new quantum sensor technologies, are expanding the applications of MEG in epilepsy diagnosis, pre-surgical planning, and advanced neuroscience research.

Market Drivers

The Global Magnetoencephalography (MEG) Devices Market is growing due to increased investments in advanced neuroimaging infrastructure, rising prevalence of neurological illnesses, and increased clinical research activities around the world. "North America continues to be strong because of robust healthcare systems and research funding, whereas Asia-Pacific is seeing faster acceptance due to healthcare modernization, neuroscience programs, and rising diagnostic demands. Europe is an important hub for MEG research, including academic cooperation and government-funded neuroscience projects. Furthermore, there is a trend of investing in next-generation technologies such as Optically Pumped Magnetometers (OPM-MEG), AI-powered data analytics, and small imaging systems to lower prices, enhance accessibility, and broaden clinical applications.

For Instance: -The Asia-Pacific region is the fastest growing regional market, driven by expanding aerospace and defense programs, semiconductor manufacturing, scientific research, and increasing investments in domestic production, nanotechnology, quantum technologies, and strategic partnerships to boost MCP manufacturing capabilities.

Restrain

High equipment and installation costs, complex infrastructure needs, and specialized maintenance requirements are among the factors impeding the growth of the Global Magnetoencephalography (MEG) Devices Market. Conventional MEG systems require cryogenic refrigeration and magnetically protected chambers, which raises operating expenses. Adoption is also hampered due to a lack of skilled specialists and low-cost neurodiagnostic devices, such as EEG and MRI. Furthermore, reimbursement issues in underdeveloped countries impact market penetration and accessibility.

Analysis of Prices and Consumer Behaviour

Whole-head MEG systems (constituting about 68-72% of the total market) lead the magnetoencephalography devices market, mainly due to their widespread acceptance in hospitals, neuroscience research centers, and epilepsy diagnosis. An SQUID-based MEG system is expected to cost USD 2.5 million to USD 3 million, 30–40% costlier than emerging compact neuroimaging solutions, due to its superconducting sensors, cryogenic cooling requirements, and magnetically shielded room infrastructure. Clinical healthcare facilities account for about 56% to 60% of all MEG device installations, reflecting the growing demand for epilepsy diagnosis, pre-surgical brain mapping, and assessment of neurological disorders. The demand comes from hospitals and dedicated neuroscience centers, which account for over 60% of the total, and from research institutions doing a lot of cognitive neuroscience and brain function work.Purchasing behavior demonstrates that about 58% of buyers consider the accuracy of diagnostics, reliability of the system and advanced data analysis capabilities, while about 32–35% of purchasers prefer procurement via government tenders, institutional funding or long term procurement agreements to reduce capital costs and guarantee long term support for service and maintenance.

Top Companies in the Global Magnetoencephalography Devices Market (H2)

1. MEGIN
2. Ricoh
3. Compumedics Neuroscan
4. CTF MEG International Services
5. FieldLine Medical
6. Kernel
7. Cerca Magnetics
8. Croton Healthcare
9. Yokogawa Electric
10. Tristan Technologies
11. Siemens Healthineers
12. Elekta
13. Nihon Kohden
14. Philips Healthcare
15. GE HealthCare

Global Magnetoencephalography Devices Market Segmentation

The Global Magnetoencephalography Devices Market share is divided into five categories: Product Type, Application, End User, Technology, and Distribution Channel.

The Whole-head MEG Systems dominated the market, accounting for nearly 60% in 2025 and is expected to rise at a significant CAGR during the forecast period.

The global Magnetoencephalography Devices Market is segmented by product type into whole-head meg systems, portable meg systems, superconducting meg systems, optically pumped meg systems, hybrid meg systems, research meg systems, others. Among these, the Whole-head MEG Systems dominated the market, accounting for nearly 60% in 2025 and expected to increase at a significant CAGR during the forecast period. Whole-head MEG systems are the market-leading technology due to their complete brain coverage, high spatial and temporal resolution, established clinical reliability and widespread use in epilepsy diagnosis, pre-surgical brain mapping, and neuroscience research.

The Neurology dominated the market, accounting for close to 43% in 2025, and is expected to rise at a significant CAGR during the forecast period.

The global Magnetoencephalography Devices Market is segmented by application into hospitals, research institutes, academic centers, specialty neurology clinics, others. Among these, the Neurology segment dominated the market, accounting for close to 43% in 2025 and expected to increase at a significant CAGR during the forecast period. Due to the increasing prevalence of neurological disorders, the widespread use of MEG devices in epilepsy diagnosis and pre-surgical brain mapping and increasing demand for precise, non-invasive brain imaging, the neurology segment holds the largest share in the market for MEG devices.

The Hospitals segment dominated the market, accounting for about 65% in 2025 and is expected to rise at a significant CAGR during the forecast period.

The global Magnetoencephalography Devices Market is segmented by end user into Hospitals segment, research institutes, healthcare facilities, semiconductor industry, aerospace companies, others. Among these, the Hospitals segment segment dominated the market, accounting for about 65% in 2025 and expected to increase at a significant CAGR during the forecast period. Hospitals segment holds the largest share of the MEG devices market due to the presence of advanced neuroimaging infrastructure, availability of skilled neurologists, increase in number of epilepsy surgeries, higher patient volume, and increased investment in specialized diagnostic technologies.

Regional Segment Analysis of the Global Magnetoencephalography Devices Market

• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe) 
• North America (U.S., Canada, Mexico)  
• Asia-Pacific (China, Japan, India, Rest of APAC) 
• South America (Brazil and the Rest of South America)  
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is expected to grow at a rapid CAGR in the global Magnetoencephalography Devices Market, holding around 40% of the share during the forecast period.

North America has the largest market share in the Global Magnetoencephalography (MEG) Devices Market owing to the well-developed healthcare infrastructure, availability of the leading MEG device manufacturers, and increasing investments in neuroscience research. The region has a high prevalence of neurological disorders, widespread adoption of advanced diagnostic technologies, favorable reimbursement policies and significant government and institutional funding. In addition, the growing use of MEG in epilepsy diagnosis, pre-surgical brain mapping, and cognitive neuroscience research is anticipated to further boost the growth of the regional market.

Europe is the fastest-growing region in the global Magnetoencephalography Devices Market during the period, holding roughly 31% share.

The Europe region is the fastest growing region in the global magnetoencephalography (MEG) devices market due to the increasing government support for neuroscience research, growing investments in advanced medical imaging technologies, and strong collaborations between hospitals, universities, and research institutes. The regional market is also driven by the increasing prevalence of neurological disorders, rising adoption of MEG for epilepsy diagnosis and pre-surgical planning, and continuous development of next-generation technologies such as Optically Pumped Magnetometer (OPM)-based systems.

Asia Pacific is the fastest-growing region in the global Magnetoencephalography Devices Market during the period, holding nearly 23% share.

Asia Pacific region is witnessing the highest growth in the Global Magnetoencephalography (MEG) Devices Market due to the rising healthcare expenditure, growing neuroscience research, and increasing investments in advanced diagnostic infrastructure. Countries such as Japan, China,South Korea and India are upgrading their neurological care, with government support and the modernization of hospitals. Increased awareness of neurological disorders, rising adoption of non-invasive brain imaging technologies and growing academic collaborations further drive the regional market.

Strategies for Market Growth in Non-Leading Regions:

The development of non-leading regions with cost-effective, scalable and helium-free MEG technologies, in particular Optically Pumped Magnetometer (OPM)-based systems, would allow for improvement of accessibility for hospitals and research institutions. Regional manufacturing, assembly and service centers can be established to reduce dependence on imports, costs of installation and maintenance. Market penetration and clinical adoption will be bolstered by strategic partnerships with hospitals, universities, neuroscience research institutes, diagnostic centers, and healthcare providers. Training programs for neurologists, neurosurgeons, radiologists, biomedical engineers and technical professionals will improve skills in MEG operation, data analysis and clinical applications . The use of flexible financing models, leasing, government funding, public-private partnerships and long-term procurement agreements will also make MEG systems more affordable and encourage wider adoption. We will be working with governments, medical research bodies, academic institutions and digital healthcare platforms to increase access to advanced neuroimaging technologies and to support sustainable market growth in emerging economies.

Future Market Trends for the Global Magnetoencephalography Devices Market: -

• Helium-free, wearable Optically Pumped Magnetometer (OPM) technology is revolutionizing the MEG market, cutting infrastructure costs, improving patient comfort, and broadening clinical and research applications.
• AI and multimodal imaging integration is boosting diagnostic accuracy, speeding up neurological data analysis and enabling advanced applications in epilepsy diagnosis, brain mapping and neuroscience research.
• The market accessibility is improving and the adoption is being driven in the hospitals, diagnostic centres and research institutions by the growing investments in the healthcare infrastructure, neuroscience research and portable MEG systems, especially in the Asia Pacific region.

Recent Development

January 2026 – Cerca Magnetics launched an advanced wearable OPM-based MEG system, enabling helium-free and patient-friendly brain imaging with enhanced mobility for pediatric and neurological research applications.

March 2026 – MEGIN Oy added AI-powered analytics to its MEG platform, improving automated epileptic spike detection, diagnostic accuracy and workflow efficiency for clinical neuroimaging.

June 2026 – Compumedics Limited strengthened its global footprint by partnering with leading neuroscience research institutions, driving the adoption of high sensitivity MEG systems in clinical and research settings.

Market Segment

This study forecasts revenue at global, regional and country levels from 2020 to 2033. Transpire Insights has segmented the global Magnetoencephalography Devices Market based on the below-mentioned segments:

Global Magnetoencephalography Devices Market, By Product Type

• Whole-head MEG Systems
• Portable MEG Systems
• Superconducting MEG Systems
• Optically Pumped MEG Systems
• Hybrid MEG Systems
• Research MEG Systems
• Others

Global Magnetoencephalography Devices Market, By Application

• Neurology
• Epilepsy Diagnosis
• Brain Mapping
• Cognitive Research
• Neurosurgery Planning
• Psychiatry Research
• Others

Global Magnetoencephalography Devices Market, By End User

• Hospitals
• Research Institutes
• Academic Centers
• Specialty Neurology Clinics
• Others

Global Magnetoencephalography Devices Market, By Technology

• SQUID-based Systems
• Optically Pumped Magnetometers
• Cryogen-free Systems
• Others

Global Magnetoencephalography Devices Market, By Distribution Channel

• Direct Sales
• Medical Equipment Distributors
• Research Equipment Suppliers
• Others

Global Magnetoencephalography Devices Market, By Regional Analysis

North America

• US 

• Canada 

• Mexico 

Europe

• Germany 

• UK 

• France 

• Italy 

• Spain 

• Russia 

• Rest of Europe 

Asia Pacific

• China 

• Japan 

• India 

• South Korea 

• Australia 

• Rest of Asia Pacific 

South America

• Brazil 

• Argentina 

• Rest of South America 

Middle East & Africa

• UAE 

• Saudi Arabia 

• Qatar 

• South Africa 

• Rest of the Middle East & Africa